top of page
HealthEquity (NASDAQ: HQY) Exceeds Q1 Expectations with Strong Earnings and Revenue Growth

HealthEquity (NASDAQ: HQY) Exceeds Q1 Expectations with Strong Earnings and Revenue Growth

  • HealthEquity (NASDAQ: HQY) reported robust financial results for Q1 2026, surpassing market expectations with strong earnings per share and revenue growth.
  • The company demonstrated significant profitability, with a notable increase in EPS and a 29% rise in net income, supported by expanding Health Savings Account (HSA) assets.
  • HealthEquity is actively returning value to shareholders through an increased stock repurchase program and maintains strong financial stability, evidenced by a low Debt-to-Equity ratio.

HealthEquity (NASDAQ: HQY) is a company that manages Health Savings Accounts (HSAs) and other consumer-directed benefits for individuals. It acts as both a custodian and administrator, helping people save for healthcare expenses. The company recently announced its financial results for the first quarter ending April 30, 2026, showing performance that exceeded market expectations.

The company reported an earnings per share (EPS) of $1.24. This figure is higher than the Zacks Consensus Estimate of $1.11 per share. It also marks a notable increase from the $0.97 per share that HealthEquity reported in the same quarter of the previous year, showing growth in its profitability per share.

HealthEquity also announced revenue of $354.64 million, which is slightly above the consensus estimate of $352.02 million. This represents a 7% increase in revenue from the year-ago period. This top-line growth contributed to a significant 29% rise in net income, which reached $69.40 million for the quarter.

Supporting this growth, the company's total Health Savings Account (HSA) assets grew by 19% to reach $37.10 billion. To return value to investors, HealthEquity repurchased $123.00 million of its stock. It also announced it is increasing its repurchase program by an additional $1.00 billion, as highlighted by GlobeNewswire.

From a valuation standpoint, HealthEquity has a Price-to-Earnings (P/E) ratio of 33.12. This metric shows what investors are willing to pay for each dollar of company earnings. The company's financial stability appears strong, with a very low Debt-to-Equity ratio of 0.02, indicating it relies minimally on debt for financing.

Want to know when to buy this stock? Download the Stocks 2 Buy app or try the Web version

Group 82_edited.png

Forecast your chosen stock price with the Stock Sentiment Map

Comments

Share Your ThoughtsBe the first to write a comment.
Copy of Logo circular simple negro.png
bottom of page